Abiomed (ABMD) Halted Ahead of FDA Meeting on Blood Pumps
Abiomed, Inc. (NASDAQ: ABMD) halted ahead of FDA advisory committee meeting over nonroller-type cardiopulmonary bypass blood pumps.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Clovis Oncology (CLVS) Announces FDA Acceptance of Rucaparib NDA for Priority Review
- Clovis Oncology (CLVS) Halted on LUDP
- Xtera Communications (XCOM) Halted, News Pending
Create E-mail Alert Related CategoriesFDA, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!